234 related articles for article (PubMed ID: 21860416)
1. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
Streicher KL; Zhu W; Lehmann KP; Georgantas RW; Morehouse CA; Brohawn P; Carrasco RA; Xiao Z; Tice DA; Higgs BW; Richman L; Jallal B; Ranade K; Yao Y
Oncogene; 2012 Mar; 31(12):1558-70. PubMed ID: 21860416
[TBL] [Abstract][Full Text] [Related]
2. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA miR-125b induces senescence in human melanoma cells.
Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
Levati L; Alvino E; Pagani E; Arcelli D; Caporaso P; Bondanza S; Di Leva G; Ferracin M; Volinia S; Bonmassar E; Croce CM; D'Atri S
Int J Oncol; 2009 Aug; 35(2):393-400. PubMed ID: 19578755
[TBL] [Abstract][Full Text] [Related]
8. Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets.
Hufbauer M; Lazić D; Reinartz M; Akgül B; Pfister H; Weissenborn SJ
J Dermatol Sci; 2011 Oct; 64(1):7-15. PubMed ID: 21763111
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA regulation of melanoma progression.
Bonazzi VF; Stark MS; Hayward NK
Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
[TBL] [Abstract][Full Text] [Related]
11. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
Felicetti F; Errico MC; Bottero L; Segnalini P; Stoppacciaro A; Biffoni M; Felli N; Mattia G; Petrini M; Colombo MP; Peschle C; Carè A
Cancer Res; 2008 Apr; 68(8):2745-54. PubMed ID: 18417445
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.
Mueller DW; Rehli M; Bosserhoff AK
J Invest Dermatol; 2009 Jul; 129(7):1740-51. PubMed ID: 19212343
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-dependent regulation of cKit in cutaneous melanoma.
Igoucheva O; Alexeev V
Biochem Biophys Res Commun; 2009 Feb; 379(3):790-4. PubMed ID: 19126397
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-21 by Ras in vivo and its role in tumor growth.
Frezzetti D; De Menna M; Zoppoli P; Guerra C; Ferraro A; Bello AM; De Luca P; Calabrese C; Fusco A; Ceccarelli M; Zollo M; Barbacid M; Di Lauro R; De Vita G
Oncogene; 2011 Jan; 30(3):275-86. PubMed ID: 20956945
[TBL] [Abstract][Full Text] [Related]
15. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
16. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
[TBL] [Abstract][Full Text] [Related]
17. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
18. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.
Uhlmann S; Zhang JD; Schwäger A; Mannsperger H; Riazalhosseini Y; Burmester S; Ward A; Korf U; Wiemann S; Sahin O
Oncogene; 2010 Jul; 29(30):4297-306. PubMed ID: 20514023
[TBL] [Abstract][Full Text] [Related]
19. Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals.
Glazov EA; McWilliam S; Barris WC; Dalrymple BP
Mol Biol Evol; 2008 May; 25(5):939-48. PubMed ID: 18281269
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in the pathogenesis of malignant melanoma.
Glud M; Gniadecki R
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):142-50. PubMed ID: 22621697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]